Physician profile
Amy M Mccoy
NPI 1184709263
$9,797.23
in general payments reported to CMS, 2019-2025
43 companies · $4,934 in 2025
The $4,934 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $317 · 2021: $506 · 2022: $1,492 · 2023: $1,506 · 2024: $731 · 2025: $4,934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $2,370 · Travel and Lodging: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $2,369.82 |
| Travel and Lodging | $800.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,579.64 | 2022-2025 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $1,687.23 | 2019-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $562.76 | 2022-2025 | |
| Abbvie INC. | $470.39 | 2019-2023 | |
| Sage Therapeutics, LLC | $267.34 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $235.45 | 2019-2024 | |
| Therapeuticsmd, INC. | $219.64 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $163.00 | 2021-2022 | |
| Baxter Healthcare | $151.17 | 2021-2025 | Perclot, Tisseel |
| Coopersurgical, INC. | $127.43 | 2022-2025 | Advincula Delineator Uterine Manipulator, Ally II Ups, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $122.29 | 2021-2025 | |
| Exeltis, USA INC. | $117.95 | 2019-2025 | Slynd |
| Astellas Pharma US INC | $117.51 | 2019-2024 | Veozah |
| Novo Nordisk INC | $101.14 | 2020-2023 | Wegovy |
| Myriad Women'S Health, INC. | $100.98 | 2023 | Myrisk |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $97.00 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $76.41 | 2023-2024 | Myfembree |
| Ethicon US, LLC | $76.07 | 2022-2025 | Stratafix, Vistaseal |
| Takeda Pharmaceuticals U.S.A., INC. | $70.55 | 2021-2023 | Trintellix |
| Organon LLC | $70.00 | 2022-2025 | Jada System, Nexplanon |
| Applied Medical Resources Corporation | $60.65 | 2021 | |
| Shield Therapeutics INC | $35.64 | 2024 | |
| Meditrina | $32.38 | 2022-2024 | |
| Axsome Therapeutics, INC. | $30.06 | 2022-2025 | Sunosi |
| Mission Pharmacal Company | $27.23 | 2019-2020 | |
| Myovant Sciences INC. | $23.99 | 2022 | |
| Scynexis, INC. | $20.68 | 2022 | |
| Smith+Nephew, INC. | $18.81 | 2024 | Pico 14 |
| Radius Health, INC. | $17.58 | 2020 | |
| Millicent US INC | $17.58 | 2020 | |
| Merck Sharp & Dohme LLC | $15.79 | 2022 | |
| Teleflex LLC | $15.11 | 2022 | |
| Avion Pharmaceuticals | $15.07 | 2019 | |
| Duchesnay USA Incorporated | $14.50 | 2019 | |
| Endo Pharmaceuticals INC. | $13.22 | 2019 | |
| Daiichi Sankyo INC. | $12.93 | 2019 | |
| Lupin INC. | $12.06 | 2020 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mccoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.